Meet Luciana Borio, M.D., Assistant Commissioner for Counterterrorism Policy
Dr. Borio is Assistant Commissioner for Counterterrorism Policy and Director, Office of Counterterrorism and Emerging Threats (OCET) in the Office of the Chief Scientist, U.S. Food and Drug Administration (FDA). Dr. Borio is leading the implementation of FDA’s Medical Countermeasures Initiative (MCMi).
Prior to joining FDA’s Center for Biologics Evaluation and Research in 2008, Dr. Borio was Senior Associate at the Center for Biosecurity of UPMC and Assistant Professor of Medicine at the University of Pittsburgh (2003-2008).
Dr. Borio served at the U.S. Department of Health and Human Services (HHS) as an Advisor on Biodefense Programs (2001 to 2008), where she implemented and managed mathematical modeling projects to assess the health effects of bioterrorism on civilians and to inform medical countermeasures procurement activities for the Office of Preparedness and Response. Dr. Borio is a member of the Infectious Diseases Society of America, where she serves on their Pandemic Influenza Task Force.
Dr. Borio received her MD in 1996 from the George Washington University. She completed residency in 1999 in Internal Medicine at the New York Presbyterian Hospital - Cornell Medical Center and subsequently completed a combined fellowship in Infectious Diseases (at Johns Hopkins University) and Critical Care Medicine (at the National Institutes of Health). Dr. Borio continues to practice medicine at Johns Hopkins Hospital.